share_log

ElectroCore Expands Intellectual Property Portfolio; Trademark Office Has Issued A Patent Related To Systems And Methods For Treating Post-traumatic Stress Disorder

Benzinga ·  Jan 9 21:10

electroCore, Inc. (NASDAQ:ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced the United States Patent and Trademark Office has issued a patent related to systems and methods for treating post-traumatic stress disorder (PTSD).

U.S. Patent No. 11,865,329 entitled "Vagal Nerve Stimulation for Treating Post-Traumatic Stress Disorder" generally relates to methods for treating the symptoms of post-traumatic stress disorder (PTSD) that include applying one or more electrical impulses transcutaneously to the vagus nerve for approximately 90 seconds to approximately 3 minutes. The electrical impulses may comprise bursts of 2 to 20 pulses.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment